Disorders of iron homeostasis are among the most common nutritional problems worldwide. Because there are no physiologic mechanisms to modulate iron excretion in humans, homeostasis depends entirely upon tightly linking dietary iron absorption with iron utilization and storage. The circulating liver peptide hepcidin appears to be a central regulator of this process. However, the means by which hepatocytes sense plasma iron and modulate hepcidin expression remain unknown. Like the classic Tf receptor (TfR1), the recently identified second Tf receptor (TfR2) mediates cellular uptake of holoTf. We propose that the role of TfR2 in the hepatoeyte is to serve as a hepatocellular sensor of circulating holoTf, and modulator of expression of the iron-regulatory peptide hepcidin. This hypothesis is supported by observations in our mouse model with a non-functional TfR2 (TfR2 YaaSX homozygous mice) It is the broad goal of this proposal to define and characterize the role of TfR2 in iron homeostasis. We have four specific aims: 1) Identify and characterize the participation of TfR2 in the hepatocellular uptake of holoTf. 2) Define the role of TfR2 in modulating the hepatocellular expression of hepcidin. 3) Distinguish the hepatocellular role of TfR2 by the cell-specific and regulatable restoration of wild-type TfR2 in TfR2 v245x mouse hepatocytes. 4) Determine the molecular basis for the functional defect caused by the TfR2 M172K mutation. These studies will identify and characterize the role of TfR2 as a hepatocellular iron sensor, and its participation in the modulation of hepcidin expression. This knowledge will increase our understanding of iron homeostasis, and may suggest new approaches to the management of diseases of iron overload and maldistribution.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK063016-01A2
Application #
6826894
Study Section
Nutrition Study Section (NTN)
Program Officer
Badman, David G
Project Start
2004-09-01
Project End
2008-06-30
Budget Start
2004-09-01
Budget End
2005-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$330,871
Indirect Cost
Name
Saint Louis University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
050220722
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Bouley, Richard; Nunes, Paula; Andriopoulos Jr, Billy et al. (2013) Heterologous downregulation of vasopressin type 2 receptor is induced by transferrin. Am J Physiol Renal Physiol 304:F553-64
Feng, Qi; Migas, Mary C; Waheed, Abdul et al. (2012) Ferritin upregulates hepatic expression of bone morphogenetic protein 6 and hepcidin in mice. Am J Physiol Gastrointest Liver Physiol 302:G1397-404
Castoldi, Mirco; Vujic Spasic, Maja; Altamura, Sandro et al. (2011) The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 121:1386-96
Fleming, Robert E; Feng, Qi; Britton, Robert S (2011) Knockout mouse models of iron homeostasis. Annu Rev Nutr 31:117-37
Corradini, Elena; Rozier, Molly; Meynard, Delphine et al. (2011) Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 141:1907-14
Chua, Anita C G; Delima, Roheeth D; Morgan, Evan H et al. (2010) Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis. J Hepatol 52:425-31
Lesnikov, Vladimir; Gorden, Nicholas; Fausto, Nelson et al. (2008) Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2. Apoptosis 13:1005-12
Waheed, Abdul; Britton, Robert S; Grubb, Jeffrey H et al. (2008) HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron. Arch Biochem Biophys 474:193-7
Drake, S F; Morgan, E H; Herbison, C E et al. (2007) Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 292:G323-8